Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

aTyr Pharma Inc (NASDAQ:LIFE)

2.94
Delayed Data
As of 3:59pm ET
 -0.07 / -2.33%
Today’s Change
2.48
Today|||52-Week Range
19.67
-70.09%
Year-to-Date
No recent news for aTyr Pharma Inc.

Today’s Trading

Previous close3.01
Today’s open3.21
Day’s range2.84 - 3.21
Volume178,908
Average volume (3 months)250,923
Market cap$71.4M
Dividend yield--
Data as of 3:59pm ET, 08/25/2016

Growth & Valuation

Earnings growth (last year)-25.21%
Earnings growth (this year)+15.68%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.62

Competitors

 Today’s
change
Today’s
% change
APDNApplied DNA Sciences...-0.01-0.34%
DRNADicerna Pharmaceutic...-0.14-4.12%
NTECIntec Pharma Ltd+0.09+1.48%
CEMIChembio Diagnostics ...+0.91+14.94%
Data as of 3:59pm ET, 08/25/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.70
Annual revenue (last year)$0.00
Annual profit (last year)-$48.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Executive Officer
John D. Mendlein
Chief Medical Officer
Sanjay Shukla
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs